Presentation and Evaluation of Immune Thrombocytopenia
Immune thrombocytopenia (ITP) often presents clinically as petechiae, bruising, and/or mucocutaneous bleeding with an acute onset. Severe bleeding at the time of presentation is rare but can be life threatening. A detailed clinical history, including a review of the patient’s family history, is important to assess for possible inherited and/or secondary causes of thrombocytopenia (see Chap. 1). The physical examination reveals an otherwise healthy individual with skin bruising, purpura, and/or petechial rash in the absence of other findings, specifically lymphadenopathy or hepatosplenomegaly, or other systemic signs/symptoms such as fever, fatigue, weight loss, malaise, and/or pain. The diagnosis of primary ITP is one of exclusion and relies on ruling out other causes of thrombocytopenia in addition to a careful review for conditions associated with secondary ITP. The initial investigations often show severe thrombocytopenia, with variable to high mean platelet volume (MPV). In otherwise typical presentations, no additional testing is needed. The role of bone marrow testing remains controversial and is generally reserved for patients with an uncertain diagnosis or an atypical course.
KeywordsThrombocytopenia Bleeding diathesis Autoimmune disorders
- 4.Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematol-Hematol J. 2005;90(6):829–32.Google Scholar
- 16.Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J, Group ITPS. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol. 2004;76(3):205–13.CrossRefPubMedGoogle Scholar